ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Achieves Record $24.5 Million Revenue in FY 2024, Showcases Technological Advancements Expands Laboratory Capabilities and Launches Advanced AI Models, Aimed at Strengthening Market Position Launches Commercial LENSai API, Offering Advanced AI-Powere

By: financialpost.com

Jul 29 2024
0
0 Views

VICTORIA, British Columbia -- ImmunoPrecise Antibodies Ltd. (“IPA”, “Company”, “we” or “us”) (NASDAQ: IPA), an artificial intelligence (AI)-driven biotherapeutic research and technology company, today announced its financial results for the fiscal year ended April 30, 2024. All numbers are expressed in Canadian dollars unless otherwise noted. Read More

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st

Virginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park

LegalShield Workplace Study Unearths Gaps in Employee-Employer Expectations About Benefits Value, Communication

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Related

Real Opens Investor Q&A Portal Ahead of Second Quarter 2024 Financial Results

osapiens raises $120 million funding round led by Growth Equity at Goldman Sachs Alternatives

Stephanie Dinkins Awarded the Ethic Award, Oscar Pomilio Blumm Forum: Art and AI Together to Help Inclusion

Is paying college athletes charity? Even in the confusing NIL era, it looks increasingly unlikely

GenFlat Holdings Announces Up to $7.2 Million Private Securities Offering

Skyharbour Signs Agreement to Sell a Portion of its Karin Uranium Property to Cosa Resources Corp.

Eat. Earn. Enjoy: Pizza Nova launches rewarding new loyalty program

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st

Virginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park

LegalShield Workplace Study Unearths Gaps in Employee-Employer Expectations About Benefits Value, Communication

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

Real Opens Investor Q&A Portal Ahead of Second Quarter 2024 Financial Results